Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$81.11

0.11 (0.14%)

06:48
10/05/16
10/05
06:48
10/05/16
06:48

Elanco to acquire U.S. feline, canine, rabies vaccines portfolio for $885M

Elanco U.S., Inc., a subsidiary of Eli Lilly (LLY), announced an agreement to acquire Boehringer Ingelheim Vetmedica, Inc.'s, or BIVI, U.S. feline, canine and rabies vaccines portfolio - as well as a fully integrated manufacturing and R&D site - for $885M, including the estimated cost of acquired inventory. The deal will diversify Elanco's U.S. companion animal portfolio by complementing its offerings for dogs and cats. The Fort Dodge, Iowa-based facility brings capacity to manufacture the acquired products as well as R&D and testing capabilities, including an on-site veterinary research center and lab space. The acquisition is anticipated to close by early 2017, subject to approval by the Federal Trade Commission and also subject to antitrust approval and closing of Boehringer Ingelheim's asset swap transaction with Sanofi (SNY).

  • 07

    Oct

  • 25

    Oct

  • 06

    Nov

LLY Eli Lilly
$81.11

0.11 (0.14%)

09/28/16
BERN
09/28/16
NO CHANGE
BERN
Biogen likely to benefit from Lilly Alzheimer's drug results, says Bernstein
Bernstein analyst Aaron Gal says that the results of a trial of Eli Lilly's (LLY) Alzheimer's drug, solanezumab, due out in late 2016 or early 2017, are likely to impact perceptions of Biogen's (BIIB) Alzheimer's drug, aducanumab. The analyst expects Lilly's solanezumab "to show at least directional evidence" of cognitive improvement, although he is "less convinced" that the impact will be clearly statistically significant. The best results from Biogen's perspective will be if Lilly's drug shows "marginal success," according to Gal. However, statistically significant results are also good for Biogen, as they will show that reducing amyloid beta does mitigate Alzheimer's symptoms, the analyst stated. And if Lilly's drug completely fails, Biogen's drug "could well succeed," given the significant differences between them, wrote Gal,who gives Biogen's aducanumab a 65% chance of success. He keeps a $345 price target and Outperform rating on Biogen.
09/27/16
09/27/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) upgraded to Buy from Neutral at Goldman with analyst Jami Rubin saying the company is entering a long lasting period of accelerating topline and earnings growth driven by its late stage pipeline. 2. AutoZone (AZO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying the company is at a positive inflection in 7 year and older vehicles, which is strongly correlated to same-store-sales. 3. Consolidated Edison (ED) upgraded to Hold from Sell at Evercore ISI with analyst Greg Gordon saying the joint settlement proposal filed in the CECONY rate case mitigates downside risk. 4. Crown Holdings (CCK) upgraded on multiple catalysts at BMO Capital with analyst Mark Wilde citing valuation, his belief that the company will resume returning cash to shareholders in 2017, and his belief that the company's results should be boosted by " a wave of domestic and offshore expansion projects." 5. Francesca's (FRAN) upgraded to Buy from Hold at Stifel with analyst Richard Jaffe saying the company's "appealing merchandise" makes it very likely that its sales will grow going forward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/16
GSCO
09/27/16
UPGRADE
Target $95
GSCO
Buy
Eli Lilly upgraded to Buy from Neutral at Goldman
Goldman analyst Jami Rubin upgraded Eli Lilly to Buy and increased its price target to $95 from $89 saying the company is entering a long lasting period of accelerating topline and earnings growth driven by its late stage pipeline. Rubin projects $12.5B of new product sales by 2020 and double digit earnings growth over the next five years, even without Sola. The analyst sees a 35%, up from 25%, probability of success for Sola with a bull case scenario that can lead to almost $7.5B in peak sales and "super charge" earnings. Even without Sola, Rubin sees favorable risk/reward given durability of earnings and said it is the least exposed to above-CPI price increases.
09/21/16
JANY
09/21/16
DOWNGRADE
Target $36
JANY
Neutral
Janney downgrades Clovis with buyout speculation at 'fever pitch'
Janney Capital analyst Roy Buchanan downgraded Clovis Oncology (CLVS) to Neutral from Buy with an increased fair value estimate of $36. Clovis is up 17c to $35.00 in late morning trading. In a research note partially titled, "May Be Right, May Be Crazy - M&A Speculation At Fever Pitch," Buchanan says there is a "finite chance" that Clovis will need to market its PARP inhibitor rucaparib by itself. He believes a late-2016 approval for rucaparib is likely. The analyst attributes his increased fair value estimate to "acquisition optionality." Reports of Takeda's (TKPYY) reserving up to $15B for acquisitions and Medivation's (MDVN) takeout have given Clovis shares a lift, Buchanan tells investors. The analyst adds that rumors surfaced yesterday of potential interest in the company from Eli Lilly (LLY).

TODAY'S FREE FLY STORIES

CPRT

Copart

$60.30

1.29 (2.19%)

18:09
02/21/17
02/21
18:09
02/21/17
18:09
Earnings
Copart reports Q2 adjusted EPS 58c, consensus 57c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

DAL

Delta Air Lines

$51.21

-0.02 (-0.04%)

18:07
02/21/17
02/21
18:07
02/21/17
18:07
Hot Stocks
Aeromexico says concludes Delta tender offer 'represents fair value' »

Grupo Aeromexico issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSS

Golden Star Resources

$0.99

0.0232 (2.40%)

18:04
02/21/17
02/21
18:04
02/21/17
18:04
Hot Stocks
Golden Star Resources sees FY17 gold production 255,000-280,000 »

Sees FY17 AISC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GSS

Golden Star Resources

$0.99

0.0232 (2.40%)

17:57
02/21/17
02/21
17:57
02/21/17
17:57
Earnings
Golden Star Resources reports Q4 adjusted EPS 1c, consensus (1c) »

Reports Q4 gold revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CY

Cypress Semiconductor

$13.12

0.22 (1.71%)

17:52
02/21/17
02/21
17:52
02/21/17
17:52
Hot Stocks
Cypress Semiconductor founder nominates two candidates for board »

T.J. Rodgers, founder and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 16

    Mar

XPO

XPO Logistics

$48.38

-0.84 (-1.71%)

, DEPO

Depomed

$15.77

-0.7 (-4.25%)

17:41
02/21/17
02/21
17:41
02/21/17
17:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: XPO…

XPO

XPO Logistics

$48.38

-0.84 (-1.71%)

DEPO

Depomed

$15.77

-0.7 (-4.25%)

WMGI

Wright Medical

$26.86

-0.1 (-0.37%)

HCLP

Hi-Crush Partners

$21.40

0.1 (0.47%)

RRGB

Red Robin

$47.50

-0.3 (-0.63%)

FSLR

First Solar

$36.62

1.78 (5.11%)

LNTH

Lantheus

$9.35

-0.1 (-1.06%)

GE

General Electric

$30.52

0.15 (0.49%)

TRCO

Tribune Media

$33.70

0.73 (2.21%)

SREV

ServiceSource

$6.05

0.22 (3.77%)

FUEL

Rocket Fuel

$2.55

0.08 (3.24%)

TXRH

Texas Roadhouse

$47.79

-0.45 (-0.93%)

WLL

Whiting Petroleum

$11.57

0.46 (4.14%)

TEX

Terex

$32.13

0.13 (0.41%)

PZZA

Papa John's

$85.63

-0.38 (-0.44%)

FE

FirstEnergy

$31.33

0.32 (1.03%)

PKD

Parker Drilling

GBT

Global Blood Therapeutics

$28.50

1.6 (5.95%)

CUZ

Cousins Properties

$8.66

0.01 (0.12%)

YUM

Yum! Brands

$67.67

-0.73 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 01

    Mar

  • 07

    Mar

  • 07

    Mar

  • 14

    Mar

  • 26

    Apr

  • 09

    May

  • 22

    Feb

GLA

GlassBridge

, IMN

Imation

$0.77

-0.0091 (-1.17%)

17:41
02/21/17
02/21
17:41
02/21/17
17:41
Hot Stocks
GlassBridge implements name change, reverse stock split »

GlassBridge Enterprises…

GLA

GlassBridge

IMN

Imation

$0.77

-0.0091 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HVT

Haverty Furniture

$22.95

0.4 (1.77%)

17:37
02/21/17
02/21
17:37
02/21/17
17:37
Earnings
Haverty Furniture reports Q4 EPS 51c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CUZ

Cousins Properties

$8.66

0.01 (0.12%)

17:36
02/21/17
02/21
17:36
02/21/17
17:36
Syndicate
Breaking Syndicate news story on Cousins Properties »

Cousins announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

CUZ

Cousins Properties

$8.66

0.01 (0.12%)

17:36
02/21/17
02/21
17:36
02/21/17
17:36
Syndicate
Cousins announces offering of 25M shares of common stock »

Cousins Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

VMI

Valmont

$143.80

0.4 (0.28%)

17:35
02/21/17
02/21
17:35
02/21/17
17:35
Hot Stocks
Valmont expects EPS to decrease on GAAP basis »

The company said "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

VMI

Valmont

$143.80

0.4 (0.28%)

17:34
02/21/17
02/21
17:34
02/21/17
17:34
Earnings
Valmont sees FY17 adjusted EPS $6.42, consensus $6.78 »

Sees FY17 revenue up -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

VMI

Valmont

$143.80

0.4 (0.28%)

17:32
02/21/17
02/21
17:32
02/21/17
17:32
Earnings
Valmont reports Q4 adjusted EPS $1.61, consensus $1.45 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GNMX

Aevi Genomics Medicine

$5.09

0.18 (3.67%)

17:31
02/21/17
02/21
17:31
02/21/17
17:31
Hot Stocks
Aevi Genomics Medicine announces expansion of collaboration with CHOP »

Aevi Genomic Medicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 21

    Mar

UNH

UnitedHealth

$160.57

2.95 (1.87%)

, SCAI

Surgical Care Affiliates

$56.59

-0.1 (-0.18%)

17:29
02/21/17
02/21
17:29
02/21/17
17:29
Hot Stocks
UnitedHealth commences exchange offer to acquire Surgical Care Affiliates »

UnitedHealth (UNH)…

UNH

UnitedHealth

$160.57

2.95 (1.87%)

SCAI

Surgical Care Affiliates

$56.59

-0.1 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNI

Silver Spring

$14.04

0.36 (2.63%)

17:28
02/21/17
02/21
17:28
02/21/17
17:28
Earnings
Silver Spring sees Q1 revenue $45M-$50M, may not compare to consensus $75.29M »

Sees Q1 billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNI

Silver Spring

$14.04

0.36 (2.63%)

17:27
02/21/17
02/21
17:27
02/21/17
17:27
Earnings
Silver Spring sees FY17 revenue $400M-$420M, consensus $331.01M »

Sees FY17 billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$78.17

-1.33 (-1.67%)

17:25
02/21/17
02/21
17:25
02/21/17
17:25
Hot Stocks
Macquarie Infrastructure sees 10% dividend growth in 2017 »

"We are also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

MIC

Macquarie Infrastructure

$78.17

-1.33 (-1.67%)

17:24
02/21/17
02/21
17:24
02/21/17
17:24
Hot Stocks
Macquarie Infrastructure raises quarterly dividend to $1.31 per share »

The MIC board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

SPN

Superior Energy

$16.62

0.2 (1.22%)

17:20
02/21/17
02/21
17:20
02/21/17
17:20
Earnings
Superior Energy reports Q4 EPS (74c), consensus (77c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TOL

Toll Brothers

$31.99

0.5 (1.59%)

17:18
02/21/17
02/21
17:18
02/21/17
17:18
Hot Stocks
Toll Brothers announces initiation of cash dividend »

Toll Brothers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

LAND

Gladstone Land

$12.49

0.24 (1.96%)

17:17
02/21/17
02/21
17:17
02/21/17
17:17
Earnings
Gladstone Land reports Q4 FFO 13.6c vs. 13.5c last quarter »

Reports Q4 revenue $4.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

HLS

HealthSouth

$42.93

0.93 (2.21%)

17:16
02/21/17
02/21
17:16
02/21/17
17:16
Earnings
HealthSouth reports Q4 adjusted EPS 72c, consensus 62c »

Reports Q4 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

  • 05

    Mar

SHO

Sunstone Hotel

$15.20

0.07 (0.46%)

17:13
02/21/17
02/21
17:13
02/21/17
17:13
Hot Stocks
Sunstone Hotel approves $300M increase to share repurchase program »

On February 17 the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SHO

Sunstone Hotel

$15.20

0.07 (0.46%)

17:11
02/21/17
02/21
17:11
02/21/17
17:11
Hot Stocks
Sunstone Hotel expects to pay a regular dividend of 5c per share throughout 2017 »

The Company expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.